Anafen

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Anafen

What is Anafen?

Anafen is a pharmaceutical formulation containing ibuprofen, which belongs to a class of medications known as non-steroidal anti-inflammatory drugs (NSAIDs). It is primarily used to manage pain, reduce inflammation, and lower fever.

Therapeutic Purpose

The medication works by inhibiting the production of prostaglandins, which are naturally occurring chemicals in the body that signal pain and trigger inflammatory responses. By reducing the levels of these chemicals, the medication helps alleviate various types of physical discomfort.

Common Applications

Anafen is frequently used to address a range of mild to moderate conditions, including:

  • Pain Relief: Effective for headaches, dental pain, and muscular aches.
  • Inflammatory Conditions: Used to reduce swelling and joint stiffness associated with various forms of arthritis.
  • Menstrual Cramps: Provides relief from primary dysmenorrhea.
  • Fever Reduction: Helps lower body temperature during febrile illnesses.

Composition and Mechanism

As an NSAID, the active ingredient ibuprofen is absorbed into the bloodstream and distributed throughout the body to target sites of injury or irritation. It is available in various strengths and forms to accommodate different patient needs, focusing on systemic relief of symptoms rather than treating an underlying infection or injury itself.

What side effects are possible with Anafen?

Possible Side Effects and Safety Information

Anafen, which contains the non-steroidal anti-inflammatory drug (NSAID) ketoprofen, has a safety profile established through regulatory review by agencies such as the FDA Center for Veterinary Medicine and Health Canada. The official documentation of adverse reactions structures the understanding of the medicine's risk profile.


Adverse Reaction Scope

The most frequently reported adverse reactions are classified by the System-Organ-Class affected, with a focus on:

  • Gastrointestinal System: Including reports of ulceration, irritation, and vomiting.
  • Renal/Urinary System: Concerns regarding potential renal (kidney) toxicity, particularly in susceptible animals.
  • General Disorders and Administration Site Conditions: Common transient reactions at the injection site.
  • Immune System: Documented reports of anaphylactic-type (hypersensitivity) reactions.

Serious Adverse Reactions and Limitations

Serious Adverse Events tracked by regulatory bodies include outcomes such as death, life-threatening reactions, and severe organ damage, notably acute renal failure and major gastrointestinal hemorrhage or ulceration.

Safety-Related Restrictions and Limitations define the boundaries for appropriate use:

  • Population-Specific Contraindications: The drug is formally restricted or contraindicated for use in specific animal populations, including those with pre-existing cardiac, hepatic, or renal disease, and often in pregnant or lactating animals.
  • Exposure Restrictions: Use is formally advised against in animals that are dehydrated or hypotensive due to increased risk of renal toxicity. Concurrent administration with other NSAIDs or glucocorticoids is restricted due to heightened risk of adverse events.
  • Monitoring: Official documents note the requirement for monitoring for clinical signs of gastrointestinal, renal, or hepatic adverse events during use.

Overdose and Emergency Response

Overdose and When to Seek Help

Anafen (Ibuprofen) overdose is defined by the manifestation of severe effects primarily impacting the Central Nervous System (CNS) and Gastrointestinal (GI) tract, as documented in official regulatory sources. Immediate action is required upon any suspected ingestion beyond regulated amounts.

Documented Overdose Presentations and Severe Outcomes

The most commonly observed manifestations include gastrointestinal symptoms (nausea, vomiting, diarrhea, stomach pain) and CNS effects such as drowsiness, dizziness, severe headache, and ringing in the ears (tinnitus). Severe, potentially life-threatening outcomes documented in regulatory literature include acute renal failure, severe GI bleeding or perforation, profound hypotension, and critical CNS depression leading to seizures or coma. The profile notes that children who ingest amounts greater than 400 mg/kg are considered at higher risk for serious toxicity, and elderly patients face increased risk for serious gastrointestinal adverse events.

Required Emergency Actions and Management

Official guidance mandates that the individual seek immediate medical attention for any suspected overdose. Contacting a Poison Control Center or calling emergency services is required for any severe or life-threatening symptoms. Treatment is strictly symptomatic and supportive, as no specific antidote is known for acute NSAID toxicity. Management procedures described in regulatory documents include administering activated charcoal for gastric decontamination and requiring hospital monitoring with continuous measurement of vital signs and organ function.

Therapeutic Uses of Anafen

What Anafen Treats: Main Uses and Benefits

Anafen is used in situations involving certain distressing symptoms across domains where additional symptomatic support is needed, contributing to easing the overall symptom load. The medication is used to address pain, fever, and inflammation.

The medicine is commonly applied in addressing symptom clusters related to physical discomfort (mild to moderate) and systemic imbalance. This makes it relevant across conditions presenting with acute episodes, such as headache, dental pain, and high temperature associated with colds or influenza. It also addresses the inflammatory symptoms of rheumatic conditions like Osteoarthritis and Rheumatoid Arthritis, as well as primary dysmenorrhea.

“It is commonly used when symptoms intensify and supportive relief is needed.”

In clinical settings marked by heightened patient distress, Anafen is used for managing symptoms that interfere with daily comfort. This support helps patients cope more steadily with difficult episodes, providing supportive relief when symptoms interfere with routine activities during symptomatic periods.


Category of Use: Pain, Fever, and Inflammation

Regulatory References

  1. IBUPROFEN tablet, film coated - DailyMed

Eligibility and Restrictions for Use

The eligibility for using Anafen (Ibuprofen) is determined by governmental regulatory bodies based on a patient's medical history, age, and physiological status. Use is restricted or strictly prohibited for several population groups.

Classification Population or Condition
Absolute Contraindication Known hypersensitivity to Ibuprofen, Aspirin, or other NSAIDs.
Absolute Contraindication Active, or history of recurrent, gastrointestinal bleeding/peptic ulcers.
Absolute Contraindication Severe renal, hepatic, or heart failure (NYHA Class IV).
Absolute Contraindication Treatment of peri-operative pain in the setting of CABG (heart bypass) surgery.
Absolute Contraindication Last Trimester of Pregnancy (starting at 30 weeks gestation).
Restricted Use Pregnancy at 20 weeks gestation and later (avoid use unless directed by a physician; limit to lowest effective dose for shortest duration).
Restricted Use History of asthma, uncontrolled hypertension, or established cardiovascular disease.
Not Recommended Infants under 3 months of age or those weighing less than 5 kg.
Special Caution Elderly patients (ge 60 years) due to increased risk of serious gastrointestinal and renal events.

Eligibility is limited by comorbidities like coagulation defects and is subject to special caution in patients with mild-to-moderate organ impairment, where function monitoring is required. Women attempting to conceive should be aware that use may impair fertility.

What should I know about interactions with other medicines?

Anafen Interactions with other medicines and products

Anafen (Ibuprofen) interacts with various medicines and substances, primarily by altering the effects of co-administered agents or increasing the risk of adverse outcomes. Regulatory bodies classify these interactions based on potential severity and mechanism.

Interaction-Related Restrictions and Constraints

  • Contraindicated Combinations: Anafen is contraindicated for the management of peri-operative pain associated with Coronary Artery Bypass Graft (CABG) surgery.
  • Other NSAIDs: Co-administration with other Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) is contraindicated due to an increased risk of serious gastrointestinal events.
  • Timing Constraint: To avoid interference with the anti-platelet effect of immediate-release, low-dose Aspirin, Anafen must be taken at least 30 minutes after or at least 8 hours before the Aspirin dose.

Clinically Significant Interaction Patterns

  • Increased Drug Exposure: Anafen can increase the plasma concentrations of Lithium and Methotrexate by reducing their renal clearance, leading to elevated exposure and potential toxicity of those medicines. Levels of Digoxin may also be increased.
  • Additive Bleeding Risk: Use with Anticoagulants (e.g., Warfarin) and Oral Corticosteroids results in an additive pharmacodynamic effect, increasing the risk of serious bleeding or gastrointestinal ulceration.
  • Reduced Therapeutic Effect: Anafen may reduce the antihypertensive effect of ACE Inhibitors and Angiotensin II Receptor Blockers (ARBs), and may diminish the natriuretic (fluid-removing) effect of Diuretics.
  • Substance Interaction: Co-administration with chronic alcohol consumption (three or more drinks per day) increases the chance of serious gastrointestinal bleeding.
  • Population Note: Use during the third trimester of pregnancy (after 30 weeks gestation) is restricted due to the documented risk of premature closure of the fetal ductus arteriosus.

Mechanism of Action

The mechanism of Anafen (Ibuprofen) is centered on the selective interruption of key biochemical processes. It exerts its influence across three primary domains: COX enzyme inhibition, central temperature regulation, and local inflammatory signaling.


Enzyme Inhibition: Targeting Prostaglandin Synthesis

The core action involves the reversible, competitive inhibition of the Cyclooxygenase (COX) enzymes, specifically both COX-1 and COX-2 isoforms. This action immediately blocks the conversion of arachidonic acid into prostaglandins (PGE2), which are potent local signaling mediators. This suppression of PGE2 synthesis modifies the fundamental chemical cascade that modulates peripheral nociceptor activity and affects the hypothalamic set point.


️ Central Modulation of Thermoregulation

Anafen's mechanism extends to the hypothalamus, the brain's temperature control center. By limiting the production of PGE2 within this area, the drug modulates the hypothalamic thermal set point when it is elevated. This central action engages the physiological mechanisms of heat dissipation, contributing to the modulation of the thermal set point.


Peripheral Influence on Inflammatory Signaling

At sites of tissue stress, the reduction in PGE2 production directly influences the surrounding environment. This helps modulate the prostaglandin-mediated signals responsible for localized phenomena such as excessive vasodilation and increased vascular permeability. The mechanism thus assists in limiting the downstream effects of these inflammatory mediators, modulating the local physiological response.

Dosage and Administration Information

How to use Anafen

Anafen (Ibuprofen) is administered via two primary routes: the oral route using dosage forms such as tablets, capsules, and suspension, and the Intravenous (IV) Infusion route, which is restricted to clinical settings. The overarching principle across all uses is to employ the lowest effective dose for the shortest duration necessary for the administration period.


Standard Dosing and Frequency

Standard oral dosing for adults typically ranges from 200 mg to 400 mg per single administration. For chronic or inflammatory conditions, the total daily dose is divided and may extend up to a maximum of 3200 mg. Doses for acute symptoms are separated by a minimum interval of four to six hours, maintaining the prescribed frequency. Oral intake may be done with food or milk to enhance tolerance, though this can slightly slow the rate of absorption.


Specialized Administration

IV infusion is designated for short-term acute use only, and the solution often requires dilution before being administered by a healthcare professional as a controlled infusion, typically lasting at least 30 minutes. Dose adjustments are utilized for certain patient groups: pediatric dosing is calculated based on body weight, and older adults typically initiate treatment at the lowest end of the prescribed dosing range to account for age-related physiological changes. If a dose is missed, the practice is to take the next dose only when it is due, maintaining the scheduled interval and never taking a double dose to compensate.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Anafen

Evidence for Use in Outcomes Related to Physical Discomfort Associated with Tendonitis or Bursitis

Research for Anafen's use in outcomes related to physical discomfort associated with tendonitis or bursitis was studied in short-term Randomized, Controlled Trials (RCTs). These studies were applied in research contexts involving fluctuating or unstable symptoms in adults. Researchers mainly examined patient-reported outcomes describing perceived discomfort and outcomes reflecting daily functioning or activity level. The findings describe patterns observed in the studies over the measured period, specifically related to outcomes linked to inflammatory or irritative states and changes in functional measures. The research provides context but not individual predictions.

Evidence for Use in Research Examining Short-Term Symptom Patterns in Minor Aches and Pains

Research examining short-term symptom patterns in minor aches and pains was studied for short-course and single-dose RCTs. These studies focused on research exploring short-term symptom changes in generally healthy adult populations experiencing common acute pain. Outcomes describing episodic or acute changes were measured, alongside the time frame required to measure a change in symptom intensity or variability. The data show patterns related to how quickly participants reported a change in pain severity. The evidence contributes to understanding symptom patterns in short, acute episodes.

Long-Term Studies and Follow-up Data

Studies have been focused on short-term symptom observation. As a result, long-term outcomes are not fully established for either indication. The available evidence, largely from short-term RCTs, only provides insight into the initial symptom observation. Information concerning the observed persistence of change and extended-duration outcomes remains limited. Research is ongoing across the drug class to address these specific questions.

What is Still Uncertain About Anafen's Research Profile

The body of research highlights what is known — and what is still uncertain — about Anafen. A major limitation is that the follow-up durations were limited in the pivotal studies. There is a lack of comprehensive, dedicated research for several populations, meaning that certainty remains low for patients outside the typical adult demographic studied. Furthermore, comparative evidence is lacking in some areas, making it difficult to fully contextualize the findings within the broader evidence landscape.

Key Studies & References

  1. Efficacy of ketoprofen vs ibuprofen and diclofenac: a systematic review of the literature and meta-analysis
  2. KETOPROFEN CAPSULES USP (Immediate-release capsules) - DailyMed (US Regulatory Labeling)

Frequently Asked Questions (FAQ)

Common questions about Anafen (FAQ)


Q: How quickly should I expect Anafen to start working?

A: Based on official product information, onset of effect is typically seen within 20 to 30 minutes after taking an oral dose. The time when the medication reaches its peak concentration in the blood, which often relates to the strongest effect, is generally reached within 1 to 2 hours.


Q: Can Anafen be taken for tension headaches?

A: Yes, regulatory documents indicate that Anafen (Ibuprofen) is used for the temporary relief of minor aches and pains, including those due to a headache. It is officially indicated to help with the acute discomfort associated with these conditions.


Q: What are the most common side effects of Anafen that people report online?

A: The most commonly reported side effects according to official safety information relate to the gastrointestinal system. These typically include milder symptoms such as stomach pain, heartburn, nausea, vomiting, gas, constipation, and diarrhea. This information emphasizes the importance of understanding the full safety profile.


Q: Are there any common over-the-counter cold medicines that interact with Anafen?

A: Yes, the official warnings state that Ibuprofen is generally not recommended for use with any other medication containing acetaminophen (which is common in cold medicines) or other NSAIDs. Co-administration increases the risk of serious adverse events.


Q: Is Anafen safe for older adults to use?

A: Official guidance emphasizes that older adults are often advised to begin treatment at the lowest end of the prescribed dosing range. Due to an increased potential for serious complications, particularly those affecting the gastrointestinal tract and cardiovascular system, initiating treatment carefully is emphasized.


Q: How long does the effect of one dose of Anafen typically last?

A: Official product labels state that one dose typically provides pain relief for a period of four to six hours. The frequency of administration is managed to maintain this effect while remaining within prescribed daily limits.


Q: Is it normal to feel a bit sleepy after taking Anafen?

A: While drowsiness is not typically listed as a primary or most common side effect, official safety information indicates that it can sometimes occur with medications containing Ibuprofen. This effect may be more noticeable if it is a combination product.


Q: Does Anafen have a 'build-up' effect in the body over time?

A: Official pharmacological studies do not show evidence of drug accumulation or enzyme induction with typical dosing. The medication is generally metabolized in the liver, and the majority is eliminated from the body within a day following administration.


Q: Can Anafen be used to treat menstrual cramps?

A: Yes, Anafen (Ibuprofen) is officially indicated for the temporary relief of minor aches and pains, and this specifically includes discomfort due to menstrual cramps, or dysmenorrhea. Its anti-inflammatory action helps to modulate the pain associated with this condition.


Q: Are there any foods or drinks I should avoid while using Anafen?

A: Official warnings specifically focus on the consumption of alcohol. Individuals who engage in chronic alcohol consumption (defined as three or more alcoholic drinks per day) are advised to avoid using Anafen, as this significantly increases the risk of serious gastrointestinal bleeding.


Q: How is Anafen eliminated from the body?

A: Anafen (Ibuprofen) is primarily processed through metabolism in the liver (hepatic metabolism). After processing, the drug and its byproducts are mostly removed from the body through the kidneys and excreted in the urine (renal excretion).


Q: Is it possible to become dependent on Anafen?

A: Ibuprofen, the active ingredient in Anafen, is not classified as a controlled substance by regulatory bodies. While cases of misuse or overdose are possible, physical dependence or NSAID use disorder is considered largely undetermined and rare based on available official data.


Q: Why is Anafen sometimes prescribed for inflammatory conditions?

A: Anafen is classified as a Non-Steroidal Anti-Inflammatory Drug (NSAID). Its core action is to reduce the production of chemical mediators that cause inflammation. This fundamental mechanism makes it an officially indicated choice for managing inflammatory conditions like various forms of arthritis.


Q: What is the average time until the peak effect of Anafen is reached?

A: Based on pharmacokinetics, the peak serum concentration of the medication—which often correlates with the therapeutic effect—is typically reached between one to two hours after the oral dose is taken.


Q: Is there a maximum number of days in a row that Anafen should be used?

A: Generally, over-the-counter (OTC) use for pain relief should be limited to a maximum of 10 consecutive days, according to official product information. Any use beyond this duration requires supervision by a healthcare professional.


Q: Is Anafen safe for use during pregnancy (in general terms)?

A: Regulatory warnings indicate that Anafen must be avoided starting at 30 weeks gestation due to a documented risk of harm to the developing fetus. Furthermore, use between 20 and 30 weeks is only recommended if strictly necessary and should be guided by professional medical advice.


Q: Where can I find reliable, easy-to-understand research on Anafen?

A: Official, easy-to-understand drug information is readily available on government-run websites that specialize in health data. Excellent resources include the National Institutes of Health (NIH) MedlinePlus Drug Information and the DailyMed database.


Q: Do children ever take Anafen for fever?

A: Yes, regulatory documents confirm that Anafen (Ibuprofen) is indicated for temporarily relieving fever, and it is commonly used in children. Official pediatric dosing guidelines are established based on a child’s body weight.


Q: Do people often report feeling dizzy after taking Anafen?

A: Based on official adverse reaction tracking, dizziness is one of the possible effects that has been reported by users of the medication. This is a known, though not necessarily common, occurrence.


Q: Is Anafen a selective or non-selective inhibitor?

A: The active ingredient in Anafen, Ibuprofen, is classified pharmacologically as a nonselective Cyclooxygenase (COX) inhibitor. This means that it works by blocking the activity of both the COX-1 and COX-2 enzymes in the body.


Q: Can Anafen be crushed or mixed into food?

A: For individuals who may have difficulty swallowing, the solid tablets can potentially be crushed and mixed with a small amount of water or other liquid to aid in administration. An oral suspension formulation is also commonly available as an alternative.


Q: What kind of benefits does Anafen provide for arthritis sufferers?

A: Anafen is officially indicated for the temporary relief of minor aches and pains, which includes those associated with minor pain of arthritis. It is used for conditions such as rheumatoid arthritis and osteoarthritis due to its anti-inflammatory properties.

How should Anafen be stored and disposed of?

Storage and Disposal Conditions for Anafen (Ibuprofen)

The medicine must be stored at Controlled Room Temperature, which is typically 20 C to 25 C (68 F to 77 F). Anafen requires protection from moisture and must be stored in its original container, which should be kept tightly closed. Liquid forms, such as oral suspension, must not be frozen.

Required Storage Constraints

Constraint Requirement
Temperature Range Controlled Room Temperature (20 C to 25 C)
Environmental Rule Protect from moisture; do not freeze
Child Safety Rule Keep out of the sight and reach of children
Stability Rule Oral suspension has an in-use period after opening

All Anafen products must be stored out of the sight and reach of children to prevent accidental ingestion. Disposal of unused or expired medicine must be carried out in accordance with local regulations and should not be thrown away via wastewater, as ibuprofen presents an environmental risk.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Anafen found in:

A-Z Index: